The deal allows Zimmer to sell Getinge’s infection control and surgical products alongside its orthopedic implants and robots ...

Zimmer Biomet and Getinge announced today announced a strategic partnership related to ambulatory surgical centers (ASCs).

Getinge’s decision to leave the surgical perfusion market will benefit LivaNova, an already dominant player in the sector that is set to capture market share, according to GlobalData experts ...

Global MedTech companies Getinge and Zimmer Biomet Holdings, Inc. announced a strategic partnership where Zimmer Biomet will ...

Datascope, a unit of Getinge, had recalled 4,454 therapeutic devices in December following a death and four serious injuries from their use. The devices are designed to help the heart pump more blood.

When Getinge started 120 years ago, the main focus was agricultural machinery, but that shifted in the 1930s to medical technology, which is what the globally recognized company is known for today.

Swedish medical equipment maker Getinge said U.S. tariffs would not undo decades of global supply chains, after it reported quarterly core earnings just below market expectations on Tuesday.

For 2022, Getinge took in net sales of nearly 28.3 billion kronor ($2.6 billion), according to its full-year earnings report (PDF), which represented a more than 5% drop compared to 2021’s ...

Getinge has good financial strength, in our view, and we do not have any major concerns about the balance sheet. The company has steadily improved its financial position over the last few years ...

Zimmer Biomet and Getinge are partnering to distribute operating room capital products to ASCs, according to a July 10 news release. The partnership offers a turnkey solution for ASCs that can access ...

Getinge’s decision to leave the surgical perfusion market will benefit LivaNova, an already dominant player in the sector that is set to capture market share, according to GlobalData experts.